BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16443520)

  • 1. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
    Holmberg L; Kikuchi K; Gooley TA; Adams KM; Hockenbery DM; Flowers ME; Schoch HG; Bensinger W; McDonald GB
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):226-34. PubMed ID: 16443520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
    Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
    Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
    Scott AP; Tey SK; Butler J; Kennedy GA
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of gastrointestinal graft-versus-host disease according to the treatment response.
    Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y
    Ann Hematol; 2018 Oct; 97(10):1951-1960. PubMed ID: 29860563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation.
    Krishna SG; Barlogie B; Lamps LW; Krishna K; Aduli F; Anaissie E
    Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):E17-21. PubMed ID: 20223723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal biopsy, rather than ileal, is appropriate to confirm the diagnosis of early gastrointestinal graft-versus-host disease.
    Minamino H; Machida H; Tominaga K; Morimoto K; Ominami M; Fukunaga S; Hosomi S; Hayashi Y; Nagami Y; Sugimori S; Kamata N; Shiba M; Nakamae H; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Ohsawa M; Hino M; Arakawa T
    Scand J Gastroenterol; 2015; 50(11):1428-34. PubMed ID: 26061619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
    Castilla C; Pérez-Simón JA; Sanchez-Guijo FM; Díez-Campelo M; Ocio E; Pérez-Persona E; López-Villar O; Vazquez L; Caballero D; San Miguel JF
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):936-41. PubMed ID: 16920559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
    Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Ganetsky A; Frey NV; Hexner EO; Loren AW; Gill SI; Luger SM; Mangan JK; Martin ME; Babushok DV; Drobyski WR; Smith J; Timlin C; Freyer CW; Stadtmauer EA; Porter DL
    Bone Marrow Transplant; 2019 Feb; 54(2):212-217. PubMed ID: 29795429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
    Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Harmsen WS; Litzow MR
    Bone Marrow Transplant; 2001 Jun; 27(11):1133-40. PubMed ID: 11551023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
    Cho BS; Yahng SA; Kim JH; Yoon JH; Shin SH; Lee SE; Choi SM; Lee DG; Eom KS; Park G; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Ann Hematol; 2013 Apr; 92(4):497-504. PubMed ID: 23180439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
    Hockenbery DM; Cruickshank S; Rodell TC; Gooley T; Schuening F; Rowley S; David D; Brunvand M; Berryman B; Abhyankar S; Bouvier M; McDonald GB
    Blood; 2007 May; 109(10):4557-63. PubMed ID: 17244684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment algorithm for gastrointestinal graft-versus-host disease].
    McDonald GB
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():73-7. PubMed ID: 21381293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Martin PJ; McDonald GB; Sanders JE; Anasetti C; Appelbaum FR; Deeg HJ; Nash RA; Petersdorf EW; Hansen JA; Storb R
    Biol Blood Marrow Transplant; 2004 May; 10(5):320-7. PubMed ID: 15111931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease.
    Hiejima E; Nakase H; Matsuura M; Honzawa Y; Higuchi H; Saida S; Umeda K; Hiramatsu H; Adachi S; Izawa K; Kawai T; Yasumi T; Nishikomori R; Heike T
    Dig Endosc; 2016 Jul; 28(5):548-55. PubMed ID: 26773564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.
    Tzung SP; Hackman RC; Hockenbery DM; Bensinger W; Schiffman K; McDonald GB
    Biol Blood Marrow Transplant; 1998; 4(1):43-8. PubMed ID: 9701391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.